KAREN A DAWES
CIK 1261506 · Chairperson of the Board · last filed 2026-05-18
KAREN A DAWES is a Chairperson of the Board who has filed 81 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for RGEN, was dated May 18, 2026. Across all open-market trades the lifetime net is −$18.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $14.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$14.11M
5
81
-$18.21M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RGEN | Director | 92,816 | $130.59 | $12.12M | -$18.17M | 51 | 2026-05-18 |
| Barinthus Biotherapeutics plc. (VACC) Delisted | Director | 1,700 | $5.00 | $8.5K | $28.9K | 5 | 2025-06-11 |
| ASRT | Director | 84,589 | $23.48 | $1.99M | -$93.0K | 4 | 2020-05-11 |
| Assertio Therapeutics, Inc (DEPO) Delisted | Director | 12,867 | — | — | $27.3K | 17 | 2018-05-10 |
| PDL BIOPHARMA, INC. (PDLI) Delisted | Chairperson of the Board | 2,250 | — | — | $0 | 4 | 2008-04-30 |
Recent Filings
81 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-18 | RGEN | Grant (A) | +995 | $0 | EDGAR |
| 2025-12-18 | RGEN | Sell (S) | −275 | -$44.3K | EDGAR |
| 2025-06-11 | Barinthus Biotherapeutics plc. (VACC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-05-19 | RGEN | Grant (A) | +973 | $0 | EDGAR |
| 2024-08-19 | RGEN | — | — | $0 | EDGAR |
| 2024-06-14 | RGEN | Exer (M) | +2,953 | $199.9K | EDGAR |
| 2024-05-20 | RGEN | Grant (A) | +803 | $0 | EDGAR |
| 2024-05-14 | Barinthus Biotherapeutics plc. (VACC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-02-28 | RGEN | Mixed | +3,626 | $1.3K | EDGAR |
| 2023-08-30 | RGEN | Mixed | +6,542 | -$11.7K | EDGAR |